top of page

OMNIPAQUE INJECTION 300 mg I/ml

Product details

Registration number: SIN05924P

Classification: Prescription Only

Active ingredients: IOHEXOL 647 mg/ml EQV IODINE

Strength: 300 mg/ml

Dosage form: INJECTION

Route: INTRAVENOUS; INTRAVASCULAR; INTRACAVITARY; INTRA-ARTERIAL; INTRATHECAL

Registrant: GE HEALTHCARE PTE. LTD.

ATC code: V08AB02

HSA approval date: 17 May 1991

Manufacturer(s):

  • GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
  • GE HEALTHCARE AS (by Parametric Release)
  • GE HEALTHCARE (SHANGHAI) CO., LTD

Manufacturing country/countries: IRELAND; NORWAY; CHINA

What are the HSA registration number and classification for OMNIPAQUE INJECTION 300 mg I/ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN05924P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for OMNIPAQUE INJECTION 300 mg I/ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: IOHEXOL 647 mg/ml EQV IODINE

Strength: 300 mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for OMNIPAQUE INJECTION 300 mg I/ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS; INTRAVASCULAR; INTRACAVITARY; INTRA-ARTERIAL; INTRATHECAL

Source for this answer

Who is the recorded registrant for OMNIPAQUE INJECTION 300 mg I/ml?

According to the HSA dataset updated 7 August 2026:

Registrant: GE HEALTHCARE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for OMNIPAQUE INJECTION 300 mg I/ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • GE HEALTHCARE IRELAND LIMITED (by Parametric Release)
  • GE HEALTHCARE AS (by Parametric Release)
  • GE HEALTHCARE (SHANGHAI) CO., LTD

Manufacturing country/countries: IRELAND; NORWAY; CHINA

Source for this answer

Where can I look up OMNIPAQUE INJECTION 300 mg I/ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN05924P or the exact product name OMNIPAQUE INJECTION 300 mg I/ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this OMNIPAQUE INJECTION 300 mg I/ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this OMNIPAQUE INJECTION 300 mg I/ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN05924P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page